Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
The National Pharmaceutical Pricing Authority (NPPA) has released the revised calculation sheet for the ceiling price of azithromycin 250 mg tablet following a review order from the Department of ...
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments: Our Bureau, Mumbai Tuesday, January 14, 2025, 09:00 Hrs ...
Boehringer Ingelheim and Synaffix B.V. (Synaffix), a Lonza company focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs ...
Astellas Pharma Inc. announced the US Food and Drug Administration (FDA) accepted the revised supplemental New Drug Application (sNDA) for Izervay (avacincaptad pegol intravitreal solution) for the ...
GSK plc, a global biopharma company, announced that the US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s ...
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing partners ...
With revision in extension of the deadline for implementing the revised Schedule M until December 31, 2025, the Indian Drug Manufacturers’ Association (IDMA) has announced plans to intensify its ...
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...
Adcentrx Therapeutics (Adcentrx), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-threatening diseases, announced the first patient dosed in ...
Union government should adopt a phased and pragmatic approach for the pharma industry to implement the extension of revised Schedule M compliance on similar lines of the practices followed by ...